From
StayCurrentMD
Hepatoblastoma: Update Course 2014
Chapter 1 of 5 · Fundamentals
PRETEXT Staging System and Case Presentation
Expert statements on this page
No expert statements were drawn from this page.
Host summaries · secondary, not cited in answers
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Video
Update Course 2023 - Updates in the use of ICG
19 min · Published Aug 2023
Video
Quality of Life Outcomes for Patients Who Underwent Conventional Resection and Liver Transplantation for Locally Advanced Hepatoblastoma
1 min · Published Jan 2026
Video
Hepatoblastoma with Dr. Greg Tiao
CCHMC Pediatric Surgery · Published Mar 2022
Video
44. Assessment of Pediatric Liver Tumors - Part 1 . By Prof. Dr. Alexander Towbin
Alexander J. Towbin · 49 min · Published May 2020
Video
Aggressive Pursuit of No Evidence of Disease Status in Hepatoblastoma Improves Survival
Published Jun 2023
Video
La búsqueda agresiva de ausencia de evidencia del estado de la enfermedad en el hepatoblastoma mejora la supervivencia
Published Jun 2023
Video
Rare Ovarian Tumor in Infants: Small Cell Carcinoma of Ovary, Hypercalcemic Type & SMARCA4 Mutation
21 s · Published Oct 2026
Video
Can Normal X-Rays Miss Metastatic Neuroblastoma? A Pediatric Radiology Case Study
26 s · Published Oct 2026
Video
Can Fractures Be a Sign of Hepatoblastoma in Children? Understanding Pediatric Liver Cancer Symptoms
37 s · Published Oct 2026
Video
Pancreas, Muscle, and Subcutaneous Fat Atrophy in Patients Undergoing Radiation for Neuroblastoma
47 s · Published Oct 2026
Podcast
Hepatoblastoma
Todd Ponsky · 54 min · Published Oct 2026
Podcast
Wilms Tumor
Todd Ponsky · 64 min · Published Oct 2026
Podcast
Diaphragm pacing as alternative to mechanical ventilation in pediatric respiratory failure
1 min · Published Nov 2026
Podcast
Fetoscopic endoluminal tracheal occlusion for congenital diaphragmatic hernia
4 min · Published Nov 2026
Podcast
FETO procedure for late-diagnosed severe CDH with liver herniation
4 min · Published Nov 2026
Podcast
Severe CDH case with FETO: unexpected anatomic findings and clinical outcome
3 min · Published Nov 2026
Podcast
Pediatric pancreatitis: diagnosis, causes, and genetic insights with Dr. Juan Gurria
3 min · Published Nov 2026
Podcast
Understanding craniosynostosis: skull sutures, growth patterns, and diagnosis in infants
10 min · Published Nov 2026
What the experts said
PRETEXT staging stands for pretreatment extent of disease and is based on segmental liver anatomy prior to chemotherapy
PRETEXT staging has a tendency to overstage because it is based purely on imaging and bulky tumors make it hard to assess true vascular invasion versus mass effect
POSTTEXT refers to extensive disease after neoadjuvant chemotherapy has been given
Key staging annotations include involvement of the retrohepatic cava or hepatic veins and the portal vein bifurcation
COG recommendations state that PRETEXT stage 2 tumors with no vascular involvement and achievable 1 cm margin can be resected upfront without neoadjuvant chemotherapy
COG feels that PRETEXT stage 1 and 2 tumors do not necessarily need referral to centers with liver resection expertise if the local surgeon feels competent
Most tumor shrinkage from chemotherapy occurs within the first two cycles
Current recommendations are that after two cycles of chemotherapy, if the tumor has not shrunk to a resectable point, the patient should be evaluated for transplant
As hepatoblastoma tumors shrink with chemotherapy, they do not shrink away from the vascular supply, so chemotherapy does not improve vascular margins
The goal surgical margin for hepatoblastoma resection is 1 cm
Survival in patients undergoing extended or heroic resections (tumor liver explants with back table resection and reimplant, portal vein reconstructions, hepatic vein reconstructions) is not as good as transplant survival
There has been a move away from heroic resections for hepatoblastoma
Patients who undergo failed resection followed by rescue transplant have worse survival than patients who undergo planned transplant upfront
Patients should be referred to a transplant center early even if they may not ultimately need transplant, to have pre-transplant evaluation completed and be plugged into the system
Primary transplant patients with hepatoblastoma do surprisingly well despite immunosuppression against rejection in the setting of cancer
For non-transplant center surgeons, criteria for proceeding with resection include feeling 95% confident of success and ability to perform an anatomic resection with good margin
Disease close to hepatic veins, disease extending across the liver, or involvement of the portal vein should prompt referral to a transplant center
The truth about resectability is determined at the time of operation despite all available imaging
In Europe, all liver tumors receive chemotherapy upfront before surgery because it results in smaller, easier-to-resect tumors
Core needle biopsy for hepatoblastoma typically requires about 10 passes through an area that includes normal parenchyma and tumor
There are two camps regarding pulmonary metastasis treatment: one advocates resecting metastases upfront before hepatectomy, the other suggests waiting until after hepatectomy because liver regeneration growth factors may stimulate previously unrecognized lung sites
There is no good data on either side of the pulmonary metastasis timing debate, with both approaches limited to a handful of patients
Papers on stage IV hepatoblastoma with lung metastases are limited to cohorts of less than 20 patients, making it hard to draw good conclusions
There may be reporting bias in transplant outcomes because successes are reported but not all failures